Kim Kelderman

CIK: 0001739054

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (5.7%)

Position reduction

Option Exercises (M)11 (31.4%)

Derivative conversions

Awards (A)8 (22.9%)

Compensation grants

Other (G, F, J, C, D, …)14 (40.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

TECH

BIO-TECHNE Corp

DirectorOfficer

CNMD

CONMED Corp

Director

Discretionary Trading P&L

Holdings

Transaction History (35 total)

CNMD
CONMED Corp
Sep 8, 2026
Exercise(M)
Direct
500 shares-
TECH
BIO-TECHNE Corp
Aug 17, 2026
Award(A)
Restricted Stock Units
Direct
93.6K shares-
TECH
BIO-TECHNE Corp
Aug 17, 2026
Award(A)
Restricted Stock Units
Direct
57.6K shares-
TECH
BIO-TECHNE Corp
Aug 15, 2026
Disposition(D)
Performance Stock Options (Right to Buy)
Direct
23.9K shares-
TECH
BIO-TECHNE Corp
Aug 15, 2026
Disposition(D)
Performance Stock Options (Right to Buy)
Direct
22K shares-
TECH
BIO-TECHNE Corp
Aug 15, 2026
Exercise(M)
Direct
21.7K shares-
TECH
BIO-TECHNE Corp
Aug 15, 2026
Disposition(D)
Performance Restricted Stock Units
Direct
8.7K shares-
TECH
BIO-TECHNE Corp
Aug 15, 2026
Disposition(D)
Performance Restricted Stock Units
Direct
8.2K shares-
TECH
BIO-TECHNE Corp
Aug 15, 2026
Tax Payment(F)
Direct
11K shares at avg. $72.40$793K
TECH
BIO-TECHNE Corp
Jul 28, 2026
Tax Payment(F)
Direct
28.7K shares at avg. $72.07$2.1M
TECH
BIO-TECHNE Corp
Jul 28, 2026
Exercise(M)
Direct
35K shares at avg. $47.60$1.7M
CNMD
CONMED Corp
Jun 1, 2026
Award(A)
RSUs (Restricted Stock Units)
Direct
5.8K shares-
TECH
BIO-TECHNE Corp
May 5, 2026
Exercise(M)
Direct
26.7K shares at avg. $47.60$1.3M
TECH
BIO-TECHNE Corp
May 5, 2026
Tax Payment(F)
Direct
24K shares at avg. $56.68$1.4M
TECH
BIO-TECHNE Corp
Apr 22, 2026
Exercise(M)
Direct
11.3K shares-
TECH
BIO-TECHNE Corp
Apr 22, 2026
Tax Payment(F)
Direct
1.4K shares at avg. $58.58$80K
TECH
BIO-TECHNE Corp
Apr 14, 2026
Exercise(M)
Direct
36.5K shares-
TECH
BIO-TECHNE Corp
Apr 14, 2026
Tax Payment(F)
Direct
32.1K shares at avg. $58.66$1.9M
TECH
BIO-TECHNE Corp
Nov 3, 2025
Tax Payment(F)
Direct
2.3K shares at avg. $62.57$144K
CNMD
CONMED Corp
Sep 8, 2025
Award(A)
RSUs (Restricted Stock Units)
Direct
500 shares-
CNMD
CONMED Corp
Sep 8, 2025
Award(A)
Options To Purchase Common Stock
Direct
6.2K shares-
TECH
BIO-TECHNE Corp
Aug 15, 2025
Exercise(M)
Direct
8.5K shares-
TECH
BIO-TECHNE Corp
Aug 15, 2025
Award(A)
Performance Restricted Stock Units
Direct
70.7K shares-
TECH
BIO-TECHNE Corp
Aug 15, 2025
Award(A)
Restricted Stock Units
Direct
35.4K shares-
TECH
BIO-TECHNE Corp
Aug 15, 2025
Award(A)
Stock Options (Right to Buy)
Direct
90.4K shares-

		Type	Shares	Price		Ownership
Sep 8, 2026	CNMD CONMED Corp	Exercise(M)	500	-	$0	Direct
Aug 17, 2026	TECH BIO-TECHNE Corp	Award(A) Restricted Stock Units	93,582	-	-	Direct
Aug 17, 2026	TECH BIO-TECHNE Corp	Award(A) Restricted Stock Units	57,590	-	-	Direct
Aug 15, 2026	TECH BIO-TECHNE Corp	Disposition(D) Performance Stock Options (Right to Buy)	23,949	-	-	Direct
Aug 15, 2026	TECH BIO-TECHNE Corp	Disposition(D) Performance Stock Options (Right to Buy)	22,044	-	-	Direct
Aug 15, 2026	TECH BIO-TECHNE Corp	Exercise(M)	21,736	-	$0	Direct
Aug 15, 2026	TECH BIO-TECHNE Corp	Disposition(D) Performance Restricted Stock Units	8,698	-	-	Direct
Aug 15, 2026	TECH BIO-TECHNE Corp	Disposition(D) Performance Restricted Stock Units	8,190	-	-	Direct
Aug 15, 2026	TECH BIO-TECHNE Corp	Tax Payment(F)	10,955	$72.40	$793,142	Direct
Jul 28, 2026	TECH BIO-TECHNE Corp	Tax Payment(F)	28,686	$72.07	$2,067,400	Direct
Jul 28, 2026	TECH BIO-TECHNE Corp	Exercise(M)	35,000	$47.60	$1,666,000	Direct
Jun 1, 2026	CNMD CONMED Corp	Award(A) RSUs (Restricted Stock Units)	5,772	-	-	Direct
May 5, 2026	TECH BIO-TECHNE Corp	Exercise(M)	26,692	$47.60	$1,270,539	Direct
May 5, 2026	TECH BIO-TECHNE Corp	Tax Payment(F)	23,951	$56.68	$1,357,543	Direct
Apr 22, 2026	TECH BIO-TECHNE Corp	Exercise(M)	11,344	-	$0	Direct
Apr 22, 2026	TECH BIO-TECHNE Corp	Tax Payment(F)	1,363	$58.58	$79,845	Direct
Apr 14, 2026	TECH BIO-TECHNE Corp	Exercise(M)	36,500	-	$0	Direct
Apr 14, 2026	TECH BIO-TECHNE Corp	Tax Payment(F)	32,088	$58.66	$1,882,282	Direct
Nov 3, 2025	TECH BIO-TECHNE Corp	Tax Payment(F)	2,303	$62.57	$144,099	Direct
Sep 8, 2025	CNMD CONMED Corp	Award(A) RSUs (Restricted Stock Units)	500	-	-	Direct
Sep 8, 2025	CNMD CONMED Corp	Award(A) Options To Purchase Common Stock	6,227	-	-	Direct
Aug 15, 2025	TECH BIO-TECHNE Corp	Exercise(M)	8,543	-	-	Direct
Aug 15, 2025	TECH BIO-TECHNE Corp	Award(A) Performance Restricted Stock Units	70,708	-	-	Direct
Aug 15, 2025	TECH BIO-TECHNE Corp	Award(A) Restricted Stock Units	35,354	-	-	Direct
Aug 15, 2025	TECH BIO-TECHNE Corp	Award(A) Stock Options (Right to Buy)	90,441	-	-	Direct

1-25 of 35 transactions

About Kelderman Kim

Kelderman Kim (SEC CIK 0001739054) files insider reports with the SEC as Chief Executive Officer of BIO-TECHNE Corp (TECH) and Director of CONMED Corp (CNMD).

Signal8 holds 18 ownership filings by Kelderman Kim (1 Form 3, 17 Form 4), filed between Sep 3, 2024 and Nov 2, 2026. Those filings report 35 transactions, from Aug 29, 2024 to Sep 8, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Kelderman Kim's filings is in MINNEAPOLIS, MN.

Recent filings by Kelderman Kim

Sep 8, 2026: Option exercise of CNMD shares (Form 4, code M).
Aug 17, 2026: Grants or awards of TECH derivative securities (2 lines, Form 4, code A).
Aug 15, 2026: Disposition to issuer transactions of TECH derivative securities (2 lines, Form 4, code D).
Aug 15, 2026: Option exercise of TECH shares (Form 4, code M).
Aug 15, 2026: Disposition to issuer transactions of TECH derivative securities (2 lines, Form 4, code D).

Other insiders filing for BIO-TECHNE Corp (TECH)

Hippel James, CFO
Geist William, PRESIDENT, PROTEIN SCIENCES
Bohnen Shane, SVP - General Counsel
Vessey Rupert, Director
Seth Alpna, Director
Klimovsky Judith V., Director

How to read Form 4 transaction codes